, 2022-07-19 02:01:00,
Renowned Experts to Support ColoAlert’s U.S. Pivotal Clinical Trial and Development of Additional Cancer Diagnostics
Dr. Wang is the GI (Gastrointestinal) Division Chief at Columbia University Vagelos College of Physicians and Surgeons and serves as Co-leader of the Tumor Biology and Microenvironment Program of the Herbert Irving Comprehensive Cancer Center
BERKELEY, Calif. and MAINZ, Germany, July 19, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the formation of a Medical Advisory Board (MAB), and the appointment of Dr. Timothy Wang as its inaugural member. The MAB will support the Company’s forthcoming U.S. pivotal trial for ColoAlert, its highly efficacious, and easy-to-use detection test for colorectal cancer (CRC) and assist Mainz in evaluating ColoAlert’s potential to address additional oncology indications along with enhancing Mainz’s pipeline of product candidates.
“We are excited to launch this advisory board and particularly pleased to build this consortium around Dr. Wang given his vast experience and domain expertise in the field of gastroenterology cancer research,” commented Guido Baechler, Chief Executive Officer of Mainz Biomed. “We look forward to making additional appointments to the MAB and working with these premier advisors to ensure ColoAlert’s planned U.S. pivotal trial is optimally positioned to succeed, and to help facilitate achieving our goal of bringing to market a robust pipeline of cutting-edge tests for early-stage detection of multiple cancers.”
Dr. Wang is a leading expert in gastroenterology cancer research and patient care. His laboratory has for decades investigated the molecular mechanisms of gastrointestinal carcinogenesis and the role of inflammation in promoting gastrointestinal neoplasia, including colon cancer. Dr. Wang is the Dorothy L. and Daniel H. Silverberg Professor of Medicine and GI Division Chief at Columbia University Vagelos College of Physicians and Surgeons and serves as Co-leader of the Tumor Biology and Microenvironment Program of the Herbert Irving Comprehensive Cancer Center.
In addition to his leadership at Columbia, Dr. Wang has served as President of the American Gastroenterology Association (AGA). His work has been recognized with numerous awards, including the Outstanding Investigator Award…
To read the original article, go to Click here